|
| |
Windhover InformationSince 1989, Windhover Information Inc. has been dedicated to providing superior analysis and commentary on health care business strategy, industry dealmaking, and marketplace trends. In the process our editorial and research staff have amassed expertise on the issues impacting the health care industry that's second to none. Windhover offers a line of products and services used by the industry's top decision-makers that provide a unique perspective on dealmaking dynamics, as well as a fundamental understanding of the strategic direction health care companies are taking. Windhover publishes In Vivo: The Business&Medicine Report, START-UP: Windhover's Review of Emerging Medical Ventures, Strategic Intelligence Systems databases and produces a series of health care industry conferences including the Pharmaceutical Strategic Alliances Conference and EuroBiotech Conference.
| Contact Details: |
| 50 Washington Street |
| South Norwalk |
| CT |
| 06854 |
| United States of America |
| Tel: | 203 838 4401 |
| Fax: | 203 838 3214 |
| Email: | kfarina@windhoverinfo.com |
| WWW: | www.windhover.com/

|
|
Loading...
|
Press Releases on Windhover Information:
|
 |
| Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover |
16th November, 2009 |
Oncothyreon Inc. |
SEATTLE, Nov. 16 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (the "Company") today announced that the Company's product candidate PX-866, a PI-3 kinase inhibitor, has been
|
| AHRQ Director Carolyn Clancy and Dr. Mark McClellan to Address Device Executives 2009 MDMA Annual Meeting |
14th April, 2009 |
Medical Device Manufacturers Association |
WASHINGTON, April 14 /PRNewswire-USNewswire/ -- Medical device industry leaders, lawmakers, and government officials will gather for the 2009 Annual Meeting of the Medical Device Manufacturers
|
| Poniard Pharmaceuticals' Picoplatin Named by Windhover Among Top 10 Most Promising Oncology Products |
21st October, 2008 |
Poniard Pharmaceuticals, Inc. |
SOUTH SAN FRANCISCO, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Poniard
Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on
oncology, today announced that its lead product
|
| Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover |
5th September, 2008 |
Expression Genetics, Inc. |
HUNTSVILLE, Ala., Sept. 5 /PRNewswire/ -- Expression Genetics, Inc. (EGEN)
announced today that the company's novel TheraPlas(R) cancer drug has been
selected as one of the Top 10 most
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 306 times since April 2007, the link to the organisation's website has been followed 61 times Search for more companies in South Norwalk Search for more companies in CT This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Windhover Information |